Quantbot Technologies LP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 160 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Quantbot Technologies LP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,997
-22.6%
4,100
+20.6%
0.00%0.0%
Q1 2023$16,796
-88.6%
3,400
-75.2%
0.00%
-90.9%
Q3 2022$147,000
-53.3%
13,700
-60.4%
0.01%
-59.3%
Q1 2022$315,000
-39.8%
34,607
-1.4%
0.03%
-35.7%
Q4 2021$523,000
+287.4%
35,107
+575.1%
0.04%
+281.8%
Q2 2021$135,000
+6650.0%
5,200
+4306.8%
0.01%
Q4 2020$2,000
-75.0%
118
-41.0%
0.00%
-100.0%
Q2 2020$8,000
-77.8%
200
-85.7%
0.00%
-75.0%
Q4 2019$36,000
-62.5%
1,400
-61.1%
0.00%
-60.0%
Q2 2019$96,0003,6000.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders